Key Aspects of Pediatric Liver Transplant Patient Visits to the Pediatric Emergency Department

Ayşe Gültekingil1, Mikail Hamza Yücel, Özlem Temel

  • 1From the Department of Pediatrics, Division of Pediatric Emergency Medicine, Baskent University Medical Faculty, Ankara, Turkey.

Insights

Pediatric liver transplant patients frequently visit the emergency department for common illnesses, with about half requiring hospitalization. Seizures and sepsis are key risk factors for pediatric intensive care unit admission in these vulnerable patients.

Area of Science:

  • Pediatric Gastroenterology
  • Transplant Hepatology
  • Emergency Medicine

Background:

  • Liver transplant recipients can experience acute and chronic complications.
  • Pediatric liver transplant patients may require emergency department (ED) care for transplant-related issues.
  • Identifying risk factors for intensive care unit (ICU) admission is crucial for managing these patients.

Purpose of the Study:

  • To describe the clinical characteristics of pediatric liver transplant patients presenting to the ED.
  • To identify risk factors associated with pediatric intensive care unit (PICU) admission in this population.

Main Methods:

  • Retrospective evaluation of pediatric liver transplant patients admitted to the ED in 2023.
  • Analysis of patient symptoms, laboratory results, hospitalization status, and diagnoses.
  • Comparison of clinical and laboratory features between patients admitted to the ICU and those not admitted.

Main Results:

  • 108 ED visits from 33 pediatric liver transplant patients were analyzed.
  • Common presentations included vomiting, fever, and respiratory symptoms; 45.4% of visits led to hospitalization.
  • Seizures and sepsis significantly correlated with ICU admission (P <.001), with earlier posttransplant time being a risk factor.

Conclusions:

  • Half of pediatric liver transplant patients presenting to the ED require hospitalization, often for supportive care.
  • While ICU admissions are infrequent, physicians must monitor for serious complications, particularly early posttransplant.
  • Close monitoring is essential due to intensive immunosuppressive therapy regimens used in early posttransplant care.
Abstract